News - Metabolics, NGM Biopharmaceuticals

Filter

Popular Filters

NGM Biopharma in deal with Janssen for novel diabetes therapeutics; Microbiotix in-licenses drugs from Merck & Co

04-01-2013

USA-based NGM Biopharmaceuticals has signed a worldwide agreement with health care giant Johnson & Johnson…

Anti-viralsDiabetesJanssenJohnson & JohnsonLicensingMBX-700MBX-701Merck & CoMetabolicsMicrobiotixNGM BiopharmaceuticalsPharmaceutical

Back to top